Daclacure 60 Mg Tablets

उत्पाद विवरण

1. Technical Specifications

2. Product Description

Daclacure 60mg Tablet contains Daclatasvir Dihydrochloride, a direct-acting antiviral (DAA) used in the treatment of Chronic Hepatitis C Virus (HCV) infection. It works by inhibiting the NS5A protein, essential for viral replication and assembly. Daclacure is not used alone; it is combined with Sofosbuvir (and sometimes Ribavirin) to increase treatment effectiveness and achieve viral clearance.

3. Product Highlights

4. Therapeutic Uses

• Chronic Hepatitis C Virus (HCV) infection in adults

• Used in combination with Sofosbuvir (with or without Ribavirin)

• Effective across multiple HCV genotypes (16)

• Helps reduce liver damage, prevents progression to cirrhosis or hepatocellular carcinoma

5. Side Effects

Common:

• Headache

• Fatigue, weakness

• Nausea, diarrhea

• Insomnia

Serious (rare):

• Bradycardia (slow heart rate, especially with amiodarone use)

• Severe allergic reactions (rash, swelling, breathing difficulty)

• Worsening of liver function in advanced cirrhosis cases

6. Precautions

• Always use in combination with Sofosbuvir, not as monotherapy

• Contraindicated in patients with severe liver impairment (Child-Pugh C) without specialist supervision

• Drug interactions: Avoid with rifampicin, carbamazepine, phenytoin, St. Johns Wort (may reduce effectiveness)

• Caution in patients with heart disease if co-administered with amiodarone (risk of severe bradycardia)

• Not recommended in pregnancy or breastfeeding unless clearly needed

• Regular monitoring of liver function tests and viral load is required during therapy